Novo Nordisk Q3 profit beats forecast; raises 2026 guidance
04/11/2026 06:33
Novo Nordisk Q3 profit beats forecast; raises 2026 guidance COPENHAGEN, Nov 4 (Reuters) - Wegovy maker Novo Nordisk NOVOb.CO reported third-quarter adjusted operating profit above expectations on Wednesday and raised its full-year profit and sales outlook.
(Reporting by Jacob Gronholt-Pedersen, editing by Terje Solsvik)
((jacob.pedersen@thomsonreuters.com Connect on LinkedIn: www.linkedin.com/in/jacobgronholt/))
Recent news on Novo Nordisk A/S
See all newsTrial failures of Novartis, Novo Nordisk heart drugs leave experts guessing
Brief: Novo Real-World Studies Link Wegovy 2.4 MG To Reductions In Liver Enzymes, Weight, Blood Sugar In Adults With Mash
Lilly to sell obesity drugs directly on Hims & Hers site (updated)
Lilly to sell obesity drugs directly on Hims & Hers site
Brief: Executive Martin Holst Lange Sold Novo Shares Worth DKK 3.4 Mln